维生素D缺乏与心脑血管疾病关系的研究进展

doi:10.3969/j.issn.1673-5765.2020.02.020

摘要/Abstract

摘要：

维生素D是一种类固醇激素，可通过与维生素D受体结合来影响心肌细胞、内皮细胞、血管平滑肌细胞和炎症细胞，发挥抑制心肌肥厚、保护血管内皮、调节炎症反应的功能，进而改善心脑血管疾病的发病风险及患者预后。维生素D缺乏可增加卒中患者的死亡风险，但应用维生素D补充剂与脑血管疾病患者预后的关系目前仍不确定。本文对维生素D缺乏与心脑血管疾病之间关系的研究进展进行综述。

文章导读： 维生素D缺乏可增加卒中患者的死亡风险，但应用维生素D补充剂与脑血管疾病患者预后的关系目前仍不确定。

关键词: 维生素D; 脑血管疾病; 相关性

Abstract:

Vitamin D is a steroid hormone, it can affect cardiomyocytes, endothelial cells, vascular smooth muscle cells and inflammatory cells by binding to the vitamin D receptors, and then can play the following roles: inhibit cardiac hypertrophy, protect vascular endothelium, regulate inflammatory reaction, which will reduce the risk of cardio-cerebrovascular diseases and improve the patients’ prognosis. Vitamin D deficiency may increase the risk of death in stroke patients. However, the relationship between vitamin D supplements and the prognosis of patients with cerebrovascular disease is still uncertain. This paper reviewed the research progress of the relationship between vitamin D deficiency and cardio-cerebrovascular diseases.

Key words: Vitamin D; Cerebrovascular disease; Relationship

房琳，马力. 维生素D缺乏与心脑血管疾病关系的研究进展[J]. 中国卒中杂志, 2020, 15(02): 209-214.

参考文献

[1] NIMITPHONG H，HOLICK M F，FRIED S K，et al.

25-hydroxyvitamin D3 and 1，25-dihydroxyvitamin

D3 promote the differentiation of human

subcutaneous preadipocytes[J/OL]. PLoS One，2012，

7（12）：e52171[2019-01-14]. https：//doi.org/10.1371/

journal.pone.0052171.

[2] SHIRVANI S S，NOURI M，SAKHINIA E，et al.

The molecular and clinical evidence of vitamin D

signaling as a modulator of the immune system：role

in Behçet’s disease[J]. Immunol Lett，2019，210：

10-19.

[3] RIENSTRA M，CHENG S，LARSON M G，et al.Vitamin D status is not related to development of

atrial fibrillation in the community[J]. Am Heart J，

2011，162（3）：538-541.

[4] NORMAN P E，POWELL J T. Vitamin D and

cardiovascular disease[J]. Circ Res，2014，114（2）：

379-393.

[5] TISHKOFF D X，NIBBELINK K A，HOLMBERG

K H，et al. Functional vitamin D receptor（VDR）in

the t-tubules of cardiac myocytes：VDR knockout

cardiomyocyte contractility[J]. Endocrinology，2008，

149（2）：558-564.

[6] GUILLOT X，SEMERANO L，SAIDENBERGKERMANAC’H

N，et al. Vitamin D and

inflammation[J]. Joint Bone Spine，2010，77（6）：

552-557.

[7] GLENN D J，CARDEMA M C，GARDNER D G.

Amplification of lipotoxic cardiomyopathy in the

VDR gene knockout mouse[J]. J Steroid Biochem

Mol Biol，2016，164：292-298.

[8] SOMJEN D，WEISMAN Y，KOHEN F，et al.

25-hydroxyvitamin D3-1alpha-hydroxylase is

expressed in human vascular smooth muscle cells

and is upregulated by parathyroid hormone and

estrogenic compounds[J]. Circulation，2005，111

（13）：1666-1671.

[9] PLAYFORD M P，DEY A K，ZIEROLD C，et

al. Serum active 1，25（OH）2D，but not inactive

25（OH）D vitamin D levels are associated with

cardiometabolic and cardiovascular disease risk in

psoriasis[J]. Atherosclerosis，2019，289：44-50.

[10] DICKIE L J，CHURCH L D，COULTHARD L R，

et al. Vitamin D3 down-regulates intracellular Tolllike

receptor 9 expression and Toll-like receptor

9-induced IL-6 production in human monocytes[J].

Rheumatology（Oxford），2010，49（8）：1466-1471.

[11] 方厚盈，邓小容，杜敏，等. 血清25-羟基维生素D水

平与急性缺血性脑卒中严重程度的分析[J]. 中国实

用神经疾病杂志，2017，20（22）：40-43.

[12] REYNOLDS J A，HAQUE S，WILLIAMSON K，

et al. Vitamin D improves endothelial dysfunction

and restores myeloid angiogenic cell function via

reduced CXCL-10 expression in systemic lupus

erythematosus[J]. Sci Rep，2016，6（1）：22341.

[13] ZHANG Y，LEUNG D Y，RICHERS B N，et

al. Vitamin D inhibits monocyte/macrophage

proinflammatory cytokine production by targeting

MAPK phosphatase-1[J]. J Immunol，2013，188（5）：

2127-2135.

[14] KOTA S K，JAMMULA S，MEHER L K，et al.

Renin-angiotensin system activity in vitamin D

deficient，obese individuals with hypertension：an

urban Indian study[J]. Indian J Endocrinol Metab，

2011，15（8）：395-401.

[15] SONI M，KOS K，LANG I A，et al. Vitamin D and

cognitive function[J]. Scand J Clin Lab Invest Suppl，

2012，243：79-82.

[16] JIANG P，ZHANG LH，CAI HL，et al.

Neurochemical effects of chronic administration of

calcitriol in rats[J]. Nutrients，2014，6（12）：6048-

6059.

[17] 关佳欣，高强，洪铭，等. 维生素D和脑白质疏松症

的研究进展[J]. 中华老年多器官疾病杂志，2017，16

（9）：708-711.

[18] 王丽娇，范鹰. 维生素D与脑血管疾病的关系[J]. 中

华老年多器官疾病杂志，2019，18（5）：390-393.

[19] YIN K，YOU Y，SWIER V，et al. Vitamin D

protects against atherosclerosis via regulation of

cholesterol efflux and macrophage polarization in

hypercholesterolemic Swine[J]. Arterioscler Thromb

Vasc Biol，2015，35（11）：2432-2442.

[20] ZHANG X L，GUO Y F，SONG Z X，et al.

Vitamin D prevents podocyte injury via regulation

of macrophage M1/M2 phenotype in diabetic

nephropathy rats[J]. Endocrinology，2014，155（12）：

4939-4950.

[21] RIEK A E，OH J，BERNAL-MIZRACHI C. 1，25

（OH）2 vitamin D suppresses macrophage migration

and reverses atherogenic cholesterol metabolism in

type 2 diabetic patients[J]. J Steroid Biochem Mol

Biol，2013，136：309-312.

[22] CANPOLAT U，AYTEMIR K，HAZIROLAN T，et

al. Relationship between vitamin D level and left

atrial fibrosis in patients with lone paroxysmal atrial

fibrillation undergoing cryoballoon-based catheter

ablation[J]. J Cardiol，2017，69（1）：16-23.

[23] HANAFY D A，CHANG S L，LU Y Y，et al.

Electromechanical effects of 1，25-dihydroxyvitamin

D with antiatrial fibrillation activities[J]. J

Cardiovasc Electrophysiol，2014，25（3）：317-323.

[24] HUANG W L，YANG J，YANG J，et al. Vitamin D

and new-onset atrial fibrillation：a meta-analysis of

randomized controlled trials[J]. Hellenic J Cardiol，

2018，59（2）：72-77.

[25] CHEN W R，LIU Z Y，SHI Y，et al. Relation

of low vitamin D to nonvalvular persistent atrial

fibrillation in Chinese patients[J]. Ann Noninvasive

Electrocardiol，2014，19（2）：166-173.

[26] DEMIR M，UYAN U，MELEK M. The effects of

vitamin D deficiency on atrial fibrillation[J]. Clin

Appl Thromb Hemost，2013，20（1）：98-103.

[27] TURIN A，BAX J J，DOUKAS D，et al. Interactions

among vitamin D，atrial fibrillation，and the renin angiotensin-aldosterone system[J]. Am J Cardiol，

2018，122（5）：780-784.

[28] ANDERSEN L B，PRZYBYL L，HAASE N，et al.

Vitamin D depletion aggravates hypertension and

target-organ damage[J/OL]. J Am Heart Assoc，2015，

4（2）：e001417[2019-01-14]. https：//doi.org/10.1161/

JAHA.114. 001417.

[29] KE L，MASON R S，MPOFU E，et al. Hypertension

and other cardiovascular risk factors are associated

with vitamin D deficiency in an urban Chinese

population：a short report[J]. J Steroid Biochem Mol

Biol，2017，173（16）：286-291.

[30] ZHANG W，CHEN L，ZHANG L，et al.

Administration of exogenous 1，25（OH）2D3

normalizes overactivation of the central reninangiotensin

system in 1α（OH）ase knockout mice[J].

Neurosci Lett，2015，588：184-189.

[31] LEUNG R Y，HAN Y，SING C W，et al. Serum

25-hydroxyvitamin D and the risk of stroke in Hong

Kong Chinese[J]. Thromb Haemost，2017，117（1）：

158-163.

[32] ZHOU R，WANG M，HUANG H，et al. Lower

vitamin D status is associated with an increased risk

of ischemic stroke：a systematic review and metaanalysis[

J/OL]. Nutrients，2018，10（3）：e277[2019-

01-14]. https：//doi.org/10.3390/nu10030277.

[33] BISCHOFF-FERRARI H A，GIOVANNUCCI E，

WILLETT W C，et a1. Estimation of optimal serum

concentrations of 25-hydroxyvitamin D for multiple

health outcomes[J]. Am J Clin Nutr，2006，84（1）：

18-28.

[34] NIE Z，JI X C，WANG J，et al. Serum levels of

25-hydroxyvitamin D predicts infarct volume

and mortality in ischemic stroke patients[J]. J

Neuroimmunol，2017，313：41-45.

[35] SAYEED I，TURAN N，STEIN D G，et al.

Vitamin D deficiency increases blood-brain barrier

dysfunction after ischemic stroke in male rats[J].

Exp Neurol，2019，312：63-71.

[36] LU B C，SHI X J，LIANG L，et al. Platelet surface

CD62p and serum vitamin D levels are associated

with clopidogrel resistance in Chinese patients with

ischemic stroke[J]. J Stroke Cerebrovasc Dis，2019，

28（5）：1323-1328.

[37] SHEERAH H A，ESHAK E S，CUI R，et al.

Relationship between dietary vitamin D and deaths

from stroke and coronary heart disease：the Japan

collaborative cohort study[J]. Stroke，2018，49（2）：

454-457.

[38] CARLUCCIO M A，DI DONATO I，PESCINI

F，et al. Vitamin D levels in cerebral autosomal

dominant arteriopathy with subcortical infarcts and

leukoencephalopathy（CADASIL）[J]. Neurol Sci，

2017，38（7）：1333-1336.

[39] FENG C，TANG N，HUANG H，et al. 25-Hydroxyvitamin

D level is associated with total MRI burden

of cerebral small vessel disease in ischemic stroke

patients[J]. Int J Neurosci，2019，129（1）：49-54.

[40] VACEK J L，VANGA S R，GOOD M，et al. Vitamin

D deficiency and supplementation and relation to

cardiovascular health[J]. Am J Cardiol，2012，109

（3）：359-363.

[41] FU J，XUE R，GU J，et al. Neuroprotective effect of

calcitriol on ischemic/reperfusion injury through the

NR3A/CREB pathways in the rat hippocampus[J].

Mol Med Rep，2013，8（6）：1708-1714.

[42] BARBARAWI M，KHEIRI B，ZAYED Y，et

al，Vitamin D supplementation and cardiovascular

disease risks in more than 83 000 individuals in 21

randomized clinical trials：a meta-analysis[J]. JAMA

Cardiol，2019，4（8）：765-776.

[43] MANSON J E，COOK N R，LEE I M，et al.

Vitamin D supplements and prevention of cancer and

cardiovascular disease[J]. N Engl J Med，2019，380

（1）：33-44.

[44] SCRAGG R，STEWART A W，WAAYER D，

et al. Effect of monthly high-dose vitamin D

supplementation on cardiovascular disease in the

vitamin D assessment study：a randomized clinical

trial[J]. JAMA Cardiol，2017，2（6）：608-616.